IPO Qilian Initernational Holdings QLI Going Public Review Valuation
We are offering 5,000,000 ordinary shares. The offering price of our Ordinary Shares in this offering will be between US $5.00 and US$7.00 per Ordinary Share.
We are an ?emerging growth company? as defined under federal securities laws and, as such, will be subject to reduced public company reporting requirements.
We are a pharmaceutical and chemical company based in China that focuses on the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (?TCMD?) product, heparin product, sausage casings, and fertilizers.